Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks

A Master of Science thesis in Biomedical Engineering by Syeda Fiza Fatima entitled, “Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks”, submitted in November 2022. Thesis advisor is Dr. Rana Sabouni. Soft copy is available (Thesis, Completion Certificate, Approval Signatures,...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Fatima, Syeda Fiza (author)
التنسيق: doctoralThesis
منشور في: 2022
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/11073/25178
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513434410811392
author Fatima, Syeda Fiza
author_facet Fatima, Syeda Fiza
author_role author
dc.contributor.none.fl_str_mv Sabouni, Rana
dc.creator.none.fl_str_mv Fatima, Syeda Fiza
dc.date.none.fl_str_mv 2022-11
2023-03-06T06:20:00Z
2023-03-06T06:20:00Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv 35.232-2022.59
http://hdl.handle.net/11073/25178
dc.language.none.fl_str_mv en_US
dc.subject.none.fl_str_mv Metal-Organic Frameworks
MOFs in drug delivery
MOFs Synthesis Techniques
MOF Characterization
Drug delivery
MOFs
Cancer
Doxorubicin
Microwave
dc.title.none.fl_str_mv Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
dc.type.none.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/doctoralThesis
description A Master of Science thesis in Biomedical Engineering by Syeda Fiza Fatima entitled, “Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks”, submitted in November 2022. Thesis advisor is Dr. Rana Sabouni. Soft copy is available (Thesis, Completion Certificate, Approval Signatures, and AUS Archives Consent Form).
format doctoralThesis
id aus_b6e0d89ce6bb87664796a6eaa2d1418d
identifier_str_mv 35.232-2022.59
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/25178
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Microwave Triggered Release of Doxorubicin from Metal-organic FrameworksFatima, Syeda FizaMetal-Organic FrameworksMOFs in drug deliveryMOFs Synthesis TechniquesMOF CharacterizationDrug deliveryMOFsCancerDoxorubicinMicrowaveA Master of Science thesis in Biomedical Engineering by Syeda Fiza Fatima entitled, “Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks”, submitted in November 2022. Thesis advisor is Dr. Rana Sabouni. Soft copy is available (Thesis, Completion Certificate, Approval Signatures, and AUS Archives Consent Form).Metal-Organic Frameworks (MOFs) are ideal candidates for a variety of applications based on their remarkable properties such as high surface area and porosity. A substantial number of studies have been conducted to examine the synthesis techniques of MOFs as well as their implementation in drug delivery, biosensing, adsorption, separation, etc. An extensive overview of the recent work performed to explore the structure, properties, and applications of MOFs was reviewed, in order to establish a strong foundation for this research. In recent times, stimuli responsive MOFs have been fabricated and investigated for their utilization in targeted drug delivery applications with the help of Ultrasound, Light and heat. We proposed the utilization of Microwaves (MW) for stimulus responsive in-vitro release of Doxorubicin (DOX) from MOFs named Fe-BTC and MIL-53(Al) for the purpose of drug delivery in cancer therapy. DOX was encapsulated into Fe-BTC and MIL-53(Al) overnight and the drug loading capacity was measured to be as high as 67% for Fe-BTC and 20-40% for MIL-53(Al). Several characterization tests were performed to confirm and explain the drug loading and releases mechanism from both MOF’s samples, including XRD, FTIR, TGA, BET, FE-SEM and EDX. Fe-BTC exhibited drug release efficiency of 54% after 50 minutes as a result of Microwave at 7.4 pH whereas 11% was achieved without Microwave. Similar observation was obtained at pH 5.3, however the release efficiencies in both cases were higher with Microwave (40%) compared to without (6%). MIL-53(Al) was observed to be more pH sensitive as it showed higher release (66%) after 38 minutes in pH 5.3as compared to 55% after 50 minutes at pH 7.4 with the application of Microwave irradiation. The experimental results revealed that both MOFs were highly heat responsive. Moreover, results of MTT assay revealed that the cells remained viable at different concentrations of the MOFs after two days of incubation verifying their biocompatibility which demonstrates that MOFs could be good candidates for tumour targeting. Additionally, the cells remained viable at different exposure lengths confirming that Microwave is a safe modality to use for triggering release of a drug from MOFs.College of EngineeringMultidisciplinary ProgramsMaster of Science in Biomedical Engineering (MSBME)Sabouni, Rana2023-03-06T06:20:00Z2023-03-06T06:20:00Z2022-11info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdf35.232-2022.59http://hdl.handle.net/11073/25178en_USoai:repository.aus.edu:11073/251782025-06-26T12:30:50Z
spellingShingle Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
Fatima, Syeda Fiza
Metal-Organic Frameworks
MOFs in drug delivery
MOFs Synthesis Techniques
MOF Characterization
Drug delivery
MOFs
Cancer
Doxorubicin
Microwave
status_str publishedVersion
title Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
title_full Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
title_fullStr Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
title_full_unstemmed Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
title_short Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
title_sort Microwave Triggered Release of Doxorubicin from Metal-organic Frameworks
topic Metal-Organic Frameworks
MOFs in drug delivery
MOFs Synthesis Techniques
MOF Characterization
Drug delivery
MOFs
Cancer
Doxorubicin
Microwave
url http://hdl.handle.net/11073/25178